Skip to main content
SpringerLink
Log in

Adalimumab

Dermatitis: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wetwittayakhlang P, et al. Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study. Journal of Gastrointestinal and Liver Diseases 31: 403-410, No. 4, 16 Dec 2022. Available from: URL: http://doi.org/10.15403/jgld-4375

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab. Reactions Weekly 1961, 17 (2023). https://doi.org/10.1007/s40278-023-41274-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-41274-8

Search

Navigation